We are live on ! Find out more
AA

Aufman Associates Portfolio holdings

AUM $251M
1-Year Est. Return 73.86%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+73.86%
3 Year Est. Return
+136.19%
5 Year Est. Return
+125.42%
10 Year Est. Return
AUM
$135M
AUM Growth
+$13.7M
Cap. Flow
+$2.43M
Cap. Flow %
1.8%
Top 10 Hldgs %
85.79%
Holding
54
New
8
Increased
14
Reduced
16
Closed

Sector Composition

Rank Sector Weight
1 Miscellaneous 73.22%
2 Technology 12.14%
3 Healthcare 3.5%
4 Real Estate 3.27%
5 Financials 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
51
PepsiCo
PEP
$183B
$211K 0.16%
+1,216
New +$199K
FHI icon
52
Federated Hermes
FHI
$4.23B
$210K 0.16%
5,580
-2,043
-27% -$70.9K
TWLO icon
53
Twilio
TWLO
$36.7B
$204K 0.15%
775
SIVB
54
DELISTED
SVB Financial Group
SIVB
$203K 0.15%
+300
New +$211K

Similar funds

Aufman Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Aufman Associates held 54 positions worth $135M, up 11% from $122M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Aufman Associates's Q4 2021 filing shows 8 new, 14 increased and 16 reduced positions. Its largest new stake was iShares ESG Aware MSCI EAFE ETF: 4,893 shares worth $389K. The largest sale was Apellis Pharmaceuticals, an estimated $271K.

By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 76% a quarter earlier, followed by Technology and Healthcare.

  • Aufman Associates's largest Q4 2021 buy was iShares ESG Aware MSCI EAFE ETF: 4,893 shares worth $389K.
  • Aufman Associates added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $631K increase.
  • Aufman Associates's biggest Q4 2021 reduction was Apellis Pharmaceuticals, cutting an estimated $271K.
  • Aufman Associates's ten largest holdings make up 86% of its $135M portfolio in Q4 2021.
  • Aufman Associates opened 8 new positions and closed 0 in Q4 2021.
  • Aufman Associates's portfolio value rose 11% quarter-over-quarter to $135M.

Based on Aufman Associates's 13F filing for Q4 2021, filed 9 Feb 2022.